Indaptus Therapeutics, Inc. (INDP) Tops Q2 EPS by 11c

Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q2 EPS of ($0.47), $0.11 better than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results